NONO and papillary renal cell carcinoma: After their discovery in papillary renal cell carcinoma (PRCC) as PRCC-TFE3 gene fusion, further partnerships have been reported, including NONO, SFPQ, and DVL2 genes in papillary renal cell carcinomas and PEComas [2].